Expert Interview
Discussing the updated data for Cretostimogene Grenadenorapvec and TAR-200 for BCG-unresponsive NMIBC presented at AUA
Ticker(s): CGON, JNJInstitution: Stony Brook Medicine
- Urologist and urologic oncologist at Stony Brook for 25 years
- Specializes in areas including the prevention of BPH as well as managing bladder and prostate cancer
- Manages 10-15 LG-IR NMIBC monthly
How may NMIBC patients do you treat?
Added By: wilson_adminWhat is the most important metric when looking at TAR-200 and creto-gren?
Added By: wilson_adminWhat is your enthusiasm for these agents on a scale of 1-10?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
